Psychedelic therapy is gaining momentum in modern mental health care—but the story isn’t simple. Joshua Bennett-Johnson, LADC-II, licensed counselor, explores both the promise and the complexity of this emerging field. Substances once dismissed are now being fast-tracked for conditions like depression, PTSD, and addiction.

Belinda Morey explores how GLP-1 medications, long-acting implants, artificial intelligence, virtual reality, and telehealth are reshaping addiction treatment in 2026. By targeting the biology of cravings and increasing consistency and accessibility, these innovations are offering new hope for sustainable recovery — while reinforcing that medication and technology work best when paired with therapy, support, and daily commitment.